Piramal Healthcare to enter financial services
Ajay Piramal-controlled Piramal Healthcare Ltd. (PHL) on Friday said it had earmarked Rs.1,000-crore investment for making foray into the financial services sector. It planned to start non-banking finance subsidiaries (NBFCs).
The company also announced the acquisition of Indiareit Fund Advisors and Indiareit Investment Management Company for Rs.225 crore.
“In view of strong growth opportunities, we plan to invest Rs.1,000 crore in the financial service sector. We have plans to enter into the financial services business, including lending and fund management for real estate and infrastructure sectors,” Piramal Group Chairman Ajay Piramal told reporters here.
Mr. Piramal said Rs.24,000 crore was available to be invested in the business pool.
Last year, Piramal Healthcare's domestic formulations business was sold to Abbott Laboratories for $3.72 billion.
It also sold its diagnostic services business to Super Religare Laboratories, owned by Malvinder and Shivinder Singh who control Fortis Healthcare (India), for Rs.600 crore.
Towards building a strong financial services business, PHL planned to acquire Indiareit Fund Advisors, a real estate private equity fund focussed on the Indian market for Rs.110 crore, Mr. Piramal said. It would also acquire Indiareit Investment Management Company for Rs.115 crore. The total funds under management were now about Rs.3,800 crore, Mr. Piramal said.
To begin with, PHL would be setting up two NBFCs for lending to infrastructure and other sectors. It will also get into fund management for real estate and infrastructure sectors, Mr. Piramal said, adding that the company was looking at inorganic growth opportunities through acquisitions in the financial sector.
Meanwhile, the board of Piramal Healthcare on Friday approved the spin-off of New Chemical Entity (NCE) from Piramal Life Sciences (PLSL).
NCE, a research unit of Piramal Life, would be demerged into PHL with effect from April 1.
The shareholders of PLSL will get one fully paid equity share of Rs.2 of PHL for every four equity shares of Rs.10 each held in PLSL.
All assets and liabilities of the NCE division would be transferred to PHL at the book value.
This demerger was expected to be completed in six months, Mr. Piramal said.
Piramal Healthcare would continue to seek acquisition opportunities in the main pharma business, even as the company was looking to diversify into non-pharma businesses, Mr. Piramal said adding that the company planned to invest Rs.200 crore for expanding capacity in its pharma solutions business.
Meanwhile, the company reported a consolidated net profit of Rs.201.85 crore for the fourth quarter ended March 31, 2011, against Rs.154.32 crore in the same period previous fiscal.
Total operating income for the quarter was up by 62 per cent at Rs.689.10 crore, which included Rs.130 crore towards income from investments.
The company's total operating income for 2010-11 was up by 27 per cent at Rs.2,009.20 crore. The net profit for the year was Rs.12,735 crore and EPS Rs.567.1 crore, a company statement said.
The board of directors has recommended a regular dividend of Rs. 6 and special one time dividend consequent to sale of domestic formulation business of Rs.6 of the face value of Rs.2 for 2010-11.
Thu Aug 20, 2015 2:24 pm by vigneshwaran0812
» Reasoning Questions for IBPS Exams
Thu Jul 23, 2015 10:54 pm by Ravinder kumar
» Apply Online for SBI Exam 2015 for 2000 PO Posts
Fri Apr 17, 2015 6:14 pm by tansika
» ICICI Bank PO Recruitment 2015: Last Date 31st Dec 2014
Mon Dec 15, 2014 6:11 pm by tansika
» SBI Associate Clerk Recruitment 2014 - Last Date Dec 9, 2014
Mon Dec 08, 2014 5:01 pm by tansika
» Practice Blood Relationship Problems
Sat Dec 06, 2014 11:23 am by tansika
» Possibility and conditional type syllogism Questions for bank P.O Exams
Sun May 25, 2014 7:05 pm by mann2231
» New Tamil Songs 2013 Free Download
Sun Feb 16, 2014 8:39 am by verimeld
» i want currentsffairs 2012 ug to dec bits and expected bits
Tue Dec 04, 2012 3:06 am by msreenivasulu